NCT06818812
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06818812
Title A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Healthcare Hematology-Oncology Santa Monica California 90404 United States Details
Sarah Cannon Research Institue At Healthone Denver Colorado 80218 United States Details
Georgetown University Hospital Washington D.C. District of Columbia 20007 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore Maryland 21287-7049 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Jefferson University Hospitals Philadelphia Pennsylvania 19107 United States Details
Scri Oncology Partners Nashville Tennessee 37203 United States Details
Md Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field